Teresa L. Rutledge

Oncology

1 University Of New Mexico
Albuquerque, NM 87131

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Developing and Implementing a Patient-Centered Opioid Prescribing Algorithm among Gynecological Oncology Patients.

Developing and Implementing a Patient-Centered Opioid Prescribing Algorithm among Gynecological Oncology Patients.

Journal: Journal of women's health (2002)

Published: May 06, 2024

Malakoplakia of the Endometrium: A Rare Unexpected Disease Raising Clinical Concern for Malignancy.

Malakoplakia of the Endometrium: A Rare Unexpected Disease Raising Clinical Concern for Malignancy.

Journal: International journal of surgical pathology

Published: May 01, 2024

Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment.

Critical decisions: A mixed-methods study of decision-making among diverse gynecologic cancer patients considering therapeutic clinical trial enrollment.

Journal: Gynecologic oncology

Published: September 29, 2023

"Care needs to be integrated" Patient and provider perspectives on a cancer shared-care model.

"Care needs to be integrated" Patient and provider perspectives on a cancer shared-care model.

Journal: Journal of cancer survivorship : research and practice

Published: September 17, 2023

Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study.

Improving Sexual and Gender Minority Cancer Care: Patient and Caregiver Perspectives From a Multi-Methods Pilot Study.

Journal: Frontiers in oncology

Published: December 10, 2021

Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State.

Characterizing Low-Risk Breast and Gynecological Cancer Patients for Transition into an Oncology/Primary Care Coordinated Care Model: Findings from a Survey of Diverse Survivors in a Rural U.S. State.

Journal: Cancers

Published: July 30, 2021

Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].

Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].

Journal: Gynecologic oncology reports

Published: September 05, 2020

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).

Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).

Journal: Gynecologic oncology reports

Published: November 18, 2019

Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Randomized phase IIB evaluation of weekly paclitaxel versus weekly paclitaxel with oncolytic reovirus (Reolysin®) in recurrent ovarian, tubal, or peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Journal: Gynecologic oncology

Published: June 27, 2017

Optimizing endometrial cancer follow-up and survivorship care for rural and other underserved women: Patient and provider perspectives.

Optimizing endometrial cancer follow-up and survivorship care for rural and other underserved women: Patient and provider perspectives.

Journal: Gynecologic oncology

Published: November 23, 2016

Ovarian Carcinoma With Isolated Spinal Cord Metastasis.

Ovarian Carcinoma With Isolated Spinal Cord Metastasis.

Journal: Journal of investigative medicine high impact case reports

Published: April 26, 2016

R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.

R-Ketorolac Targets Cdc42 and Rac1 and Alters Ovarian Cancer Cell Behaviors Critical for Invasion and Metastasis.

Journal: Molecular cancer therapeutics

Published: May 26, 2015

Showing 1-12 of 19

Last Updated: 09/26/2026